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OPEN
ORIGINAL ARTICLE
Commingling effect of gynoid and android fat patterns on
cardiometabolic dysregulation in normal weight
American adults
IS Okosun1, JP Seale2 and R Lyn3
AIM: To determine the independent and commingling effect of android and gynoid percent fat (measured using Dual Energy X-Ray
Absorptiometry) on cardiometabolic dysregulation in normal weight American adults.
METHODS: The 2005–2006 data (n= 1802) from the United States National Health and Nutritional Examination Surveys (NHANES)
were used in this study. Associations of android percent fat, gynoid percent fat and their joint occurrence with risks of
cardiometabolic risk factors were estimated using prevalence odds ratios from logistic regression analyses.
RESULTS: Android-gynoid percent fat ratio was more highly correlated with cardiometabolic dysregulation than android percent
fat, gynoid percent fat or body mass index. Commingling of android and gynoid adiposities was associated with much greater odds
of cardiometabolic risk factors than either android or gynoid adiposities. Commingling of android and gynoid adiposities was
associated with 1.75 (95% conﬁdence interval (CI) = 1.42–2.93), 1.48 (95% CI = 1.32–1.91), 1.61 (95% CI = 1.50–1.89), 3.56
(95% CI = 2.91–4.11) and 1.86 (95% CI = 1.49–1.96) increased odds of elevated glucose, elevated blood pressure, elevated low-
density lipoprotein-cholesterol, elevated triglyceride and low high-density lipoprotein-cholesterol, respectively.
CONCLUSIONS: Normal weight subjects who present with both android and gynoid adiposities should be advised of the
associated health risks. Both android and gynoid fat accumulations should be considered in developing public health strategies for
reducing cardiometabolic disease risk in normal weight subjects.
Nutrition & Diabetes (2015) 5, e155; doi:10.1038/nutd.2015.5; published online 18 May 2015
INTRODUCTION
Adiposity is a heterogeneous and multifaceted disorder in which
subgroups of obese subjects present varying cardiometabolic
proﬁles. Three of the well-known adiposity subgroups include
metabolically healthy obese subjects, metabolically unhealthy
obese subjects and metabolically healthy normal weight subjects.
Metabolically healthy obese subjects have normal metabolic
proﬁles despite elevated body fat.1,2 Paradoxically, metabolically
healthy obese subjects seem to be protected from metabolic
disorders. Indeed, numerous studies have found that metaboli-
cally healthy obese subjects have high levels of insulin sensitivity
and favorable lipids proﬁles as well as absence of dyslipidemia,
diabetes and hypertension.3–6 Metabolically unhealthy obese
subjects, on the other hand, have clusters of cardiometabolic risk
factors.7 Metabolically healthy normal weight subjects are
characterized by normal metabolic proﬁles and normal body
weight. Compared with metabolically healthy normal weight
subjects, metabolically healthy obese subjects and metabolically
unhealthy obese subjects have increased risk of developing type
2 diabetes, cardiovascular diseases and all-cause mortality.8,9
Metabolically healthy normal weight subjects often do not present
with clusters of metabolic and cardiovascular risk factors similar to
what is often associated with being overweight or obese such as
elevated fasting glucose, insulin resistance, increased triglyceride
and decreased high-density lipoprotein (HDL)-cholesterol levels,
and systemic inﬂammation.10 It is estimated that the metabolically
unhealthy normal weight and metabolically healthy normal
weight subgroups represent about 25% and 35% of the
population, respectively.10,11 Whereas many of the adiposity
phenotypes are deﬁned using body mass index (BMI), little is
known about normal weight subjects who are abdominally obese
and their risks for cardiometabolic risk factors.
Abdominal fat accumulation (deﬁned using waist circumfer-
ence) is a more potent correlate of cardiovascular diseases than
generalized fat accumulation. The major advantage of waist
circumference is the ease of measurement, but its major limitation
in determining abdominal adiposity is that it does not take into
account body build.12,13 Hence, the International Society for
Clinical Densitometry recommends Dual Energy X-Ray Absorptio-
metry (DEXA) for measuring abdominal adiposity.14 The advan-
tage of DEXA includes speed, ease of use and low radiation
exposure.15,16 DEXA’s ability to accurately and precisely measure
body fat mass in various body compartments has been well
validated.17 The joint occurrence of trunk (android) and hip
(gynoid) fat accumulations that is independent of BMI is a yet to
be well-described obesity phenotype. There are no available data
regarding the association between DEXA-deﬁned abdominal fat
accumulation (elevated android percent fat) and cardiometabolic
derangement in a sample of normal weight American adults.
Using a more accurate measurement of site-speciﬁc body fat
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may provide a better understanding on the role of abdominal fat
accumulation in cardiovascular diseases.
The aims of this study are to determine: (i) the association of DEXA-
deﬁned elevated android and gynoid percent fat with cardiometa-
bolic risk factors, (ii) whether commingling of android and gynoid
percent fat is associated with greater cardiometabolic deregulation
than their independent effect in normal weight American adults.
METHODS AND PROCEDURES
Study design
The 2005–2006 data from the United States National Health and
Nutritional Examination Surveys (NHANES) were used in this study. These
surveys are based on cross-sectional sampling designs that collect health-
related information from noninstitutionalized American adults. NHANES
participants were interviewed in their homes and subsequently received
physical and laboratory examinations in mobile examination centers.
Detailed description of the NHANES methodologies has been published
elsewhere,18 and is also available at the National Center for Health
Statistics (NCHS) website.19 The surveys were based on stratiﬁed, multi-
stage probability sampling technique. The stages of sample selection were
as follows: (i) Primary Sampling Units were counties or small groups of
contiguous counties; (ii) segments within Primary Sampling Units (a block
or group of blocks containing a cluster of households); (iii) households
within segments; and (iv) one or more participants within households.18
The institutional review board of NCHS approved the protocol for the
NHANES.
Study population
This study was restricted to normal weight (BMIo25) adults 18 years and
older (n=1802) who were assayed using DEXA and with values for the
following variables: sex, age, waist circumference, height, weight and
fasting plasma glucose (FPG), oral glucose tolerance test, triglycerides,
HDL-cholesterol, low-density lipoprotein-cholesterol (LDL-cholesterol),
triglycerides, blood pressure (BP), and android and gynoid percent fat.
Measures
In the survey that was used in this analysis, sex, age and race/ethnicity were
determined as reported by participants. In NHANES, anthropometric
measures and biological samples were obtained in mobile examination
centers. Descriptions of variable measurements and assays are available
online.18 Waist circumference was obtained using nonelastic tape and
assessed above the right iliac crest at the mid-axillary line. Height was
measured using a ﬁxed stadiometer with a vertical backboard and a
moveable headboard. Weight was measured at a standing position using a
Toledo digital weight scale (Seritex, Carlstadt, NJ, USA), and measurement
was made at the end of a normal expiration and to the nearest 0.1 kg. Three
consecutive BP readings were obtained at a one-time examination visit
using a standard protocol. In this investigation, averages of the three systolic
(SBP) and diastolic BP (DBP) readings were used as representative of the
participants' SBP and DBP values.
In NHANES, lipids (triglycerides, HDL-cholesterol and blood glucose)
were measured after 8 h of an overnight fast. Triglycerides and glucose
were measured enzymatically in serum using a series of coupled reactions
after hydroxylation into glycerol. HDL-cholesterol measurements for the
2005–2006 surveys were attained using a direct immunoassay technique.
The Fairview Medical Center Laboratory at the University of Minnesota
performed glucose measurements using the Roche/Hitachi 911 Analyzer
(Roche Diagnostics, Indianapolis, IN, USA). Fasting glucose was measured
according to a hexokinase enzymatic method.18,19 LDL-cholesterol was
calculated using Friedewald’s equation [LDL-cholesterol = total cholesterol-
HDL-cholesterol-(1/5) triglycerides] if triglycerides were less than 400mg
dl− 1.
In NHANES, entire body DEXA scans were administered in the mobile
examination center and the Hologic APEX software was used in the scan
analysis to deﬁne the android and gynoid regions. The android area is
roughly the area around the waist between the mid-point of the lumbar
spine and the top of the pelvis while the gynoid area lies roughly between
the head of the femur and mid-thigh.19
Deﬁnition of terms
Normal weight was deﬁned as BMI value of less than 25 kg m−2 and greater
than 18 kg m−2. Elevated triglyceride was deﬁned as triglyceride of ⩾ 150mg
dl−1.20 Low HDL-cholesterol was deﬁned as o40mg dl− 1 in males and
o50mg dl−1 in females.20 Elevated LDL-cholesterol was deﬁned as 100md
dl− 1 or greater. Elevated BP was deﬁned as (i) SBP (mean SBP) ⩾ 130 or (ii)
DBP (mean DBP) ⩾ 85mmHg or (iii) treatment for previously diagnosed
hypertension or (iv) taking a BP medication.20 Elevated glucose was deﬁned
as fasting plasma value of 125mg dl−1 or greater. In this study, smoking was
categorized as smokers and nonsmokers, and moderate alcohol intake as
consuming more than two alcoholic drinks per day for men and one drink
per day for women.21
Elevated android and gynoid percent fat. Subjects were divided into sex-
speciﬁc tertiles of android percent fat as follows: ﬁrst tertile (411.4% men,
419.9% women), second tertile (418.3 men, 428.1% women) and third
tertile (427.1% men,435.8% women). Tertiles of gynoid percent fat were
also computed as follows: ﬁrst tertile (413.7% men, 432.3% women),
second tertile (419.7% men, 436.7% women) and third tertile (425.5%
men, 439.7% women). Subjects with in the third tertile of android and
gynoid percent fat were regarded as having elevated android and gynoid
fat, respectively. Joint occurrence of android and gynoid fat accumulation
was determined as having android and gynoid percent fat of427.1% and
425.5%, respectively, for men. The analogous values for women were
435.8% and 439.7%, respectively. Android-gynoid percent fat ratio was
deﬁned as android fat divided by gynoid fat. Android-gynoid percent fat
ratio is a pattern of body fat distribution that is associated with an
increased risk for metabolic syndrome in healthy adults.22,23 Android-
gynoid percent fat ratio is an important predictor metabolic and
cardiovascular disease risk in normal weight as well as overweight and
obese children.24
Statistical analyses
All study analyses were conducted using SAS for Windows version 9.2 (SAS
Institute, Inc., Cary, NC, USA) and SAS callable SUDAAN. To account for the
unequal probability of selection, oversampling and nonresponse, the
appropriate sample weights, strata and cluster variables were utilized.
Descriptive statistics were performed using the survey frequency and
survey means function in SAS. We assessed cardiovascular risk of elevated
android and gynoid percent fat rates by clustering of cardiometabolic risk
factors
(two or more, three or more and four or more cardiometabolic risk factors
that includes elevated glucose, elevated BP, elevated LDL-cholesterol,
elevated triglycerides and low HDL-cholesterol).
Overall and sex-speciﬁc correlations of android, gynoid, android-gynoid
percent fat and BMI with cardiometabolic risk factors were assessed using
age-, smoking- and alcohol intake-adjusted Pearson’s correlation methods.
Independent associations between elevated android and gynoid percent
fat, and their joint occurrence (independent variables) with cardiometa-
bolic dysregulations (elevated glucose, elevated BP, elevated LDL-
cholesterol, elevated triglycerides, low HDL-cholesterol) were assessed
using odds ratios from multiple logistic regression models. In all the logistic
regression models, statistical adjustments were made for age, smoking and
alcohol intake, and P-values of o0.05 and 95% conﬁdence intervals were
used to establish statistical signiﬁcance.
RESULTS
Basic characteristics of studied population
The basic anthropometric and clinical characteristics of the
studied population of normal weight men (n= 1171) and women
(n= 685) are shown in Table 1. The studied population had BP,
triglycerides, FPG, LDL-cholesterol, HDL-cholesterol and total
cholesterol values that were within the National Cholesterol
Education Program recommendations. Men had statistically
signiﬁcant higher values of body weight, waist circumference,
BP and triglycerides, and presented with higher rates of smoking
when compared with women (Po0.01). Women had statistically
signiﬁcant higher values of android and gynoid percent fat when
compared with men (Po0.01). There were no signiﬁcant gender
differences for age, BMI, FPG, LDL-cholesterol, HDL-cholesterol and
total cholesterol differences.
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Rates of cardiometabolic abnormality according to adiposity
phenotype
Prevalences of android percent fat by the number of cardiometa-
bolic risk factors were determined (Figure 1) using values427.1%
and 435.8%, for men and women, respectively, while gynoid
percent fat was determined using values of425.5% and439.7%,
for men and women, respectively. As shown, there were
statistically signiﬁcant gender differences in rates of android and
gynoid percent fat at every level of cardiometabolic risk numbers.
In men, the rate of android percent fat for subjects with 0, 1–3 and
4–5 cardiometabolic risk factors were 9.5%, 34% and 51.9%
compared with 20%, 37% and 53%, for women, respectively. In
men, the rate of gynoid percent fat for subjects with 0, 1–3 and
4–5 cardiometabolic risk factors were 1.9%, 2.3% and 2.6%
compared to 12.8%, 17.6% and 23.1%, for women, respectively.
Correlation analysis
We investigated age-, sex-, smoking- and alcohol intake-adjusted
overall and sex-speciﬁc degrees of correlation of android percent
fat, gynoid percent fat, android-gynoid percent fat ratio and BMI
with cardiometabolic risk factors (Table 2). Overall, android
percent fat was positively and signiﬁcantly correlated with LDL-
cholesterol (r= 0.131), and negatively correlated with triglycerides
(r=− 0.113) and HDL-cholesterol (r=− 0.183), after and adjusting
for age, sex, smoking and alcohol intake. Overall, gynoid percent
fat was positively and signiﬁcantly correlated with triglycerides
(r=− 0.138), HDL-cholesterol (r= 0.143) and negatively correlated
with mean SBP (r=− 0.183) and FPG (r= 0.168). The degrees of
correlation of android-gynoid percent fat ratio with cardiometa-
bolic risk factors were higher than those between android percent
fat or gynoid percent fat with cardiometabolic risk factors.
Controlling for age, sex, smoking and alcohol intake, android-
gynoid percent fat ratio was positively correlated with DBP
(r= 0.122), SBP (r= 0.203), triglycerides (r= 0.370), FPG (r= 0.180),
LDL-cholesterol (r= 0.175) and total cholesterol (r= 0.102) and
negatively correlated with HDL-cholesterol (r=− 0.384). Overall,
BMI was less highly correlated with the cardiometabolic risk
factors that were investigated compared with android-gynoid
percent fat ratio. Controlling for age, sex, smoking and alcohol
intake, BMI was positively correlated with mean SBP (r= 0.136),
triglycerides (r= 0.251), LDL-cholesterol (r= 0.170), and negatively
correlated with HDL-cholesterol (r=− 0.347).
In men, android percent fat was positively and signiﬁcantly
correlated with triglycerides (r= 0.307), LDL-cholesterol (r= 0.208)
and total serum cholesterol (r= 0.154), and negatively correlated
with HDL-cholesterol (r=− 0.344). Gynoid percent fat was
positively and signiﬁcantly correlated with triglycerides
(r= 0.169), LDL-cholesterol (r= 0.197) and total serum cholesterol
(r= 0.164), and negatively correlated with HDL-cholesterol
(r=− 0.226). In men, android-gynoid percent fat ratio was
positively correlated with mean DBP (r= 0.112), mean SBP
(r= 0.115), triglycerides (r= 0.281) and LDL-cholesterol (r= 0.227),
and negatively correlated with HDL-cholesterol (r=− 0.384),
controlling for age, smoking and alcohol intake. Similar to the
results of the overall data, BMI was less positively correlated with
triglycerides (r= 0.244) and LDL-cholesterol (r= 0.167), and nega-
tively correlated with HDL-cholesterol (r=− 0.278), controlling for
age, sex, smoking and alcohol intake.
Table 1. Basic anthropometric and clinical characteristics of eligible subjects
Variable All (n=1802) Men (n= 1117) Women (n= 685) P-value
Age (year) 34.9± 15.4 34.7± 15.9 35.1± 15.0 0.103
Weight (kg) 62.9± 9.7 68.7± 8.4 57.1± 7.0 o0.001
Waist circumference (cm) 79.9± 7.1 82.4± 7.8 77.4± 5.8 o0.001
Body mass index (kg m−2) 22.0 ± 2.0 22.3± 2.0 21.7± 2.1 0.128
Diastolic blood pressure (mmHg) 67.6± 11.1 67.6± 12.0 67.7± 10.3 o0.001
Systolic blood pressure (mmHg) 115.7± 15.1 118.8± 14.3 112.8± 15.2 o0.001
Triglycerides (mg dl− 1) 95.2± 59.3 102.2± 66.0 86.8± 48.7 0.014
Fasting plasma glucose (mg dl− 1) 97.4± 32.4 100.0± 33.7 94.3± 28.8 0.431
LDL-cholesterol (mg dl− 1) 105.2± 32.7 105.8± 32.8 104.5± 32.6 0.393
HDL-cholesterol (mg dl− 1) 59.7± 16.3 55.7± 15.5 63.9± 16.0 0.131
Total cholesterol (mg dl− 1) 183.3± 38.4 181.1± 38.9 185.5± 37.8 0.399
Android percent fat 23.0± 8.1 18.8± 6.9 27.2± 7.0 o0.001
Gynoid percent fat 27.7± 9.7 16.9± 5.3 36.0± 5.1 o0.001
Smoking (%) 36.9 47.7 25.9 o0.001
Alcohol intake (%) 14.4 14.1 14.6 0.835
Abbreviations: HDL-cholesterol, high-density lipoprotein-cholesterol; LDL-cholesterol, low-density lipoprotein cholesterol.
Figure 1. Prevalence of android and gynoid adiposity by numbers of
cardiometabolic risk factors in non-overweight American adults.
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In women, android percent fat was positively correlated with
triglycerides (r= 0.224) and LDL-cholesterol (r= 0.138), and nega-
tively correlated with HDL-cholesterol (r=− 0.251), while gynoid
percent fat was negatively correlated with only HDL-cholesterol
(r=− 0.152). In women, android-gynoid percent fat ratio was
positively correlated with triglycerides (r= 0.329) and FPG
(r= 0.168), and negatively correlated with HDL-cholesterol
(r=− 0.219). Similar to males, BMI was also negatively correlated
with HDL-cholesterol (r=− 0.157), after controlling for age, sex,
smoking and alcohol intake.
Association of android and gynoid fat patterns with
cardiometabolic dysregulation
Results of overall (Table 3) and sex-speciﬁc analyses (Tables 4 and 5)
of association of android and gynoid fat patterns and their
combined effects on cardiometabolic dysregulation, including
elevated glucose, BP, LDL-cholesterol, triglycerides and low HDL-
cholesterol were determined using age-, BMI-, smoking- and
alcohol intake-adjusted logistic regression models. In both overall
and sex-speciﬁc analyses, commingling of elevated android and
gynoid percent was much more associated with higher odds of
elevated glucose, elevated BP, elevated LDL-cholesterol, elevated
glycerides and elevated triglycerides and lower odds of low HDL-
cholesterol compared with either android or gynoid percent fat.
Overall (Table 3), and after adjusting for age, BMI, sex, smoking
and alcohol intake, elevated android percent fat was associated
with increased odds of elevated glucose (OR= 1.31; 95% CI =
1.12–2.93), elevated BP (OR = 1.42; 95% CI = 1.22–2.11), elevated
LDL-cholesterol (OR = 1.22; 95% CI = 1.03–1.60), elevated triglycer-
ides (OR = 2.59; 95% CI = 1.61–3.98) and low HDL-cholesterol
(OR= 1.79; 95% CI = 1.47–1.89). Elevated gynoid percent fat was
associated with decreased odds of elevated glucose (OR= 0.87;
95% CI = 0.72–0.93), elevated BP (OR = 0.80; 95% CI = 0.71–0.98),
elevated triglycerides (OR= 0.91; 95% CI = 0.81–0.98) and low HDL-
cholesterol (OR= 0.81; 95% CI = 0.52–0.91), controlling for age, sex,
smoking and alcohol intake. Overall, commingling of elevated
Table 2. Partial correlations between android percent fat, gynoid
percent fat, android-gynoid percent fat ratio and BMI with
cardiometabolic risk factors
Variables Android
% fat
Gynoid
% fat
Android-gynoid
% fat ratio
Body
mass index
Overall
MDBP 0.020 0.070 0.122** 0.046
MSBP − 0.022 − 0.183** 203** 0.136**
TG − 0.113** 0.138** 0.370** 0.251**
FPG 0.033 − 0.168** 0.180** 0.028
HDL-cholesterol − 0.183** 0.143** − 0.384** − 0.347**
LDL-cholesterol 0.131** − 0.025 0.175* 170**
TChol 0.090 − 0.001 0.102* 0.072
Men
MDBP 0.074 0.009 0.112* 0.072
MSBP 0.063 0.009 0.115* 0.094
TG 0.307* 0.169** 0.281** 0.244**
FPG − 0.033 − 0.096 0.090 − 0.064
HDL-cholesterol − 0.344** − 0.226** − 0.349** − 0.278**
LDL-cholesterol 0.208** 0.197** 0.227** 0.167**
TChol 0.154** 0.164** 0.058 0.102
Women
MDBP − 0.002 − 0.054 0.037 0.077
MSBP 0.079 − 0.017 0.096 0.045
TG 0.224** 0.009 0.329** 0.065
FPG 0.081 − 0.034 0.168* 0.057
HDL-cholesterol − 0.251** − 0.152* − 0.219* − 0.157*
LDL-cholesterol 0.138** 0.082 0.137 0.008
TChol 0.064 0.004 0.106 0.048
Abbreviations: FBG, fasting plasma glucose; HDL-cholesterol, high-density
lipoprotein-cholesterol; LDL-cholesterol, low-density lipoprotein-choles-
terol; MDBP, mean diastolic blood pressure; MSBP, mean systolic blood
pressure; TChol, Total serum cholesterol; TG, triglyceride. **Po0.01;
*Po0.05.
Table 3. Associations between android percent fat, gynoid percent fat and their joint occurrence on cardiometabolic deregulations
Independent variable Cardiometabolic risk factors
Elevated glucose Elevated BP Elevated LDL-C Elevated triglycerides Low HDL-C
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
EAF 1.31 (1.12–2.93) 1.42 (1.22–2.11) 1.22 (1.03–1.60) 2.59 (1.61–3.98) 1.79 (1.47–1.89)
Age 1.09 (1.05–1.07) 1.06 (1.05–1.07) 1.04 (1.03–1.06) 1.01 (0.99–1.02) 1.02 (1.01–1.03)
BMI 1.14 (0.98–1.35) 1.09 (1.04–1.15) 1.11 (1.05–1.19) 1.18 (1.10–1.27) 0.89 (0.85–0.94)
Sexa 1.31 (0.37–4.58) 1.40 (0.98–2.01) 1.33 (0.85–2.08) 3.41 (1.62–7.17) 0.59 (0.38–0.92)
Smoking 1.26 (0.53–3.00) 1.37 (1.05–1.77) 0.88 (0.68–1.39) 1.54 (1.00–2.36) 0.86 (0.64–1.16)
Alcohol 2.25 (2.01–5.31) 1.09 (0.78–1.52) 0.87 (0.52–1.45) 0.82 (0.46–1.47) 0.57 (0.39–0.82)
EGF 0.87 (0.72–0.93) 0.80 (0.71–0.98) 0.78 (0.73–1.10) 0.91 (0.81–0.98) 0.81 (0.52–0.91)
Age 1.09 (1.05–1.12) 1.06 (1.05–1.08) 1.05 (1.03–1.06) 1.01 (0.99–1.02) 1.01 (1.01–1.04)
BMI 1.15 (1.09–1.35) 1.07 (1.04–1.15) 1.11 (1.05–1.19) 1.22 (1.10–1.27) 0.86 (0.81–0.97)
Sexa 0.36 (0.25–2.49) 1.72 (0.86–3.45) 0.80 (0.34–1.90) 1.74 (0.41–3.77) 0.65 (0.21–1.54)
Smoking 1.17 (1.03–3.00) 1.31 (1.11–1.79) 0.90 (0.68–1.39) 1.19 (1.00–2.36) 0.86 (0.61–1.21)
Alcohol 2.21 (1.41–5.31) 1.07 (1.05–1.50) 0.86 (0.52–1.45) 0.81 (0.46–1.47) 0.56 (0.44–0.92)
EAF and EGF 1.75 (1.42–2.93) 1.48 (1.32–1.91) 1.61 (1.50–1.89) 3.56 (2.91–4.11) 1.86 (1.49–1.96)
Age 1.09 (1.05–1.09) 1.06 (1.04–1.08) 1.05 (1.03–1.06) 1.01 (0.99–1.02) 1.02 (1.01–1.03)
BMI 1.17 (1.08–1.35) 1.08 (1.05–1.21) 1.12 (1.05–1.20) 1.26 (1.17–1.37) 0.87 (0.83–0.95)
Sexa 1.08 (0.28–4.20) 1.44 (1.00–2.15) 1.50 (0.93–2.40) 3.67 (1.58–8.65) 0.66 (0.41–1.07)
Smoking 1.22 (1.13–3.00) 1.35 (1.15–1.88) 0.95 (0.68–1.39) 1.25 (1.18–2.36) 0.87 (0.74–1.26)
Alcohol 2.19 (1.91–5.31) 1.07 (1.01–1.52) 0.86 (0.52–1.45) 0.80 (0.46–1.47) 0.56 (0.45–0.81)
Abbreviations: BMI, body mass index; BP, blood pressure; CI, conﬁdence intervals; EAF, elevated android %fat; EGF, elevated gynoid %fat; HDL-C, High-density
lipoprotein-cholesterol; LDL-C, Low-density lipoprotein-cholesterol; OR, odds ratio from multivariate logistic regression analysis. aValue is for male; if the 95%
CI does not contain the value 1.0, the association is statistically signiﬁcant at alpha = 0.05.
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android and gynoid percent was associated with increased odds
of elevated glucose (OR= 1.75; 95% CI = 1.42–2.93), elevated
BP (OR= 1.48; 95% CI = 1.32–1.91), elevated LDL-cholesterol
(OR= 1.61; 95% CI = 1.50–1.89), elevated triglycerides (OR= 3.56;
95% CI = 2.91–4.11) and low HDL-cholesterol (OR = 1.86; 95%
CI = 1.49–1.96), adjusting for age, BMI, sex, smoking and alcohol
intake.
In men (Table 4), elevated android percent fat was associated
with increased odds of elevated BP (OR = 1.21; 95% CI = 1.06–1.77),
elevated triglycerides (OR= 2.41; 95% CI = 2.03–5.75) and low HDL-
cholesterol (OR= 1.23; 95% CI = 1.19–1.89), adjusting for age, BMI,
smoking and alcohol intake. After adjusting for covariates,
elevated gynoid percent fat was signiﬁcantly associated with
decreased odds of elevated LDL-cholesterol (OR = 0.82; 95%
CI = 0.76–0.90), while commingling of android percent fat and
gynoid percent fat was associated with increased odds of elevated
glucose (OR = 1.51; 95% CI = 1.42–2.93), elevated BP (OR= 1.48;
95% CI = 1.32–1.91), elevated LDL-cholesterol (OR = 1.55; 95%
CI = 1.30–1.99), elevated triglycerides (OR = 2.47; 95% CI = 2.21–
3.98) and low HDL-cholesterol (OR = 1.65; 95% CI = 1.51–2.93).
Table 4. Associations between android percent fat, gynoid percent fat and their joint occurrence on cardiometabolic deregulations in American
men
Independent variable Cardiometabolic risk factors
Elevated glucose Elevated BP Elevated LDL-C Elevated triglycerides Low HDL-C
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
EAF 0.59 (0.21–1.67) 1.21 (1.06–1.77) 0.81 (0.46–1.40) 2.41 (2.03–5.75) 1.23 (1.19–1.89)
Age 1.07 (1.03–1.11) 1.05 (1.04–1.06) 1.05 (1.04–1.07) 1.01 (0.99–1.02) 1.01 (1.00–1.03)
BMI 1.07 (0.88–1.30) 1.08 (1.05–1.24) 1.16 (1.06–1.26) 1.12 (1.03–1.23) 0.84 (0.79–0.91)
Smoking 0.77 (0.28–2.13) 1.27 (0.98–1.81) 0.79 (0.50–1.25) 1.29 (0.80–2.09) 0.95 (0.66–1.37)
Alcohol 0.53 (0.20–1.43) 1.08 (0.76–1.22) 0.97 (0.49–1.95) 1.47 (0.76–2.87) 1.70 (1.08–2.69)
EGF 0.51 (0.42–1.93) 0.86 (0.79–1.08) 0.82 (0.76–0.90) 0.97 (0.71–1.18) 0.65 (0.57–1.01)
Age 1.07 (1.06–1.11) 1.05 (1.01–1.06) 1.05 (1.03–1.08) 1.01 (0.99–1.02) 1.02 (1.01–1.04)
BMI 1.11 (1.09–1.33) 1.07 (1.02–1.25) 1.15 (1.11–1.29) 1.23 (1.11–1.37) 0.82 (0.80–0.96)
Smoking 0.73 (1.03–2.10) 1.28 (1.11–1.79) 0.83 (0.78–1.19) 1.13 (1.07–2.26) 0.96 (0.63–1.20)
Alcohol 1.94 (1.41–5.31) 0.92 (0.85–1.10) 0.99 (0.82–1.35) 0.78 (0.51–1.22) 0.57 (0.45–0.93)
EAF and EGF 1.51 (1.42–2.93) 1.48 (1.32–1.91) 1.55 (1.30–1.99) 2.47 (2.21–3.98) 1.65 (1.51–2.93)
Age 1.07 (1.06–1.09) 1.06 (1.04–1.08) 1.03 (1.03–1.06) 1.01 (0.99–1.02) 1.02 (1.01–1.03)
BMI 1.11 (1.09–1.35) 1.08 (1.05–1.21) 1.06 (1.05–1.20) 1.23 (1.14–1.27) 0.82 (0.83–0.95)
Smoking 0.73 (0.73–2.01) 1.35 (1.15–1.88) 0.83 (0.68–1.39) 1.38 (1.18–2.36) 0.96 (0.74–1.26)
Alcohol 1.94 (1.91–3.31) 1.07 (1.01–1.52) 1.00 (0.52–1.45) 0.78 (0.46–1.47) 0.57 (0.45–0.81)
Abbreviations: BMI, body mass index; BP, blood pressure; CI, conﬁdence intervals; EAF, elevated android %fat; EGF, elevated gynoid %fat; HDL-C, High-density
lipoprotein-cholesterol; LDL-C, Low-density lipoprotein-cholesterol; OR, odds ratio from multivariate logistic regression analysis; if the 95% CI does not contain
the value 1.0, the association is statistically signiﬁcant at alpha = 0.05.
Table 5. Associations between android percent fat, gynoid percent fat and their joint occurrence on cardiometabolic deregulations in American
women
Independent variable Cardiometabolic risk factors
Elevated glucose Elevated BP Elevated LDL-C Elevated triglycerides Low HDL-C
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
EAF 1.28 (0.33–2.44) 0.84 (0.47–1.48) 1.53 (0.74–8.59) 2.85 (0.94–3.65) 1.52 (1.29–2.93)
Age 1.22 (1.06–1.42) 1.08 (1.06–1.10) 1.03 (0.99–1.07) 1.03 (1.01–1.06) 1.01 (1.00–1.03)
BMI 1.33 (0.86–2.07) 1.00 (0.90–1.10) 0.99 (0.80–1.23) 0.98 (0.88–1.09) 0.96 (0.88–1.06)
Smoking 7.34 (0.89–9.38) 1.23 (0.72–2.09) 1.52 (0.49–4.07) 1.27 (0.68–2.36) 0.61 (0.37–1.03)
Alcohol 0.34 (0.21–2.61) 0.69 (0.38–1.24) 0.88 (0.22–3.48) 1.39 (0.63–1.47) 1.88 (0.99–3.58)
EGF 0.87 (0.72–0.93) 0.82 (0.71–0.99) 0.92 (0.78–1.10) 0.89 (0.61–2.98) 0.59 (0.52–0.91)
Age 1.29 (1.05–1.12) 1.08 (1.05–1.08) 1.04 (1.03–1.06) 1.03 (0.99–1.02) 1.01 (1.01–1.04)
BMI 1.15 (1.09–1.35) 1.01 (1.04–1.15) 1.04 (1.05–1.19) 1.15 (1.10–1.27) 0.92 (0.81–0.97)
Smoking 1.38 (1.03–3.00) 1.21 (1.11–1.79) 1.16 (0.68–1.39) 1.29 (1.00–2.36) 0.63 (0.61–1.21)
Alcohol 2.50 (1.41–5.31) 1.44 (1.05–1.50) 0.68 (0.52–1.45) 0.95 (0.46–1.47) 0.54 (0.44–0.92)
EAF and EGF 2.24 (2.01–2.93) 1.82 (1.62–1.91) 1.77 (1.50–1.89) 3.56 (2.61–3.98) 1.70 (1.49–2.93)
Age 1.22 (1.05–1.09) 1.06 (1.04–1.08) 1.03 (1.01–1.06) 1.03 (0.99–1.02) 1.01 (1.00–1.04)
BMI 1.33 (1.08–1.35) 1.08 (1.05–1.21) 0.97 (1.05–1.20) 1.02 (1.17–1.37) 0.96 (0.85–0.91)
Smoking 1.35 (1.13–3.00) 1.35 (1.15–1.88) 1.31 (0.68–1.39) 1.45 (1.18–2.36) 1.61 (0.54–1.07)
Alcohol 3.01 (1.91–5.31) 1.07 (1.01–1.52) 0.72 (0.52–1.45) 1.07 (0.46–1.47) 0.53 (0.49–0.88)
Abbreviations: BMI, body mass index; BP, blood pressure; CI, conﬁdence intervals; EAF, elevated android %fat; EGF, elevated gynoid %fat; HDL-C, High-density
lipoprotein-cholesterol; LDL-C, Low-density lipoprotein-cholesterol; OR, odds ratio from multivariate logistic regression analysis; if the 95% CI does not contain
the value 1.0, the association is statistically signiﬁcant at alpha = 0.05.
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In women (Table 5), after adjusting for age, BMI, smoking
and alcohol intake, elevated android percent fat was only
signiﬁcantly associated with increased odds of low HDL-
cholesterol (OR = 1.52; 95% CI = 1.29–2.93). After adjusting
for covariates, elevated gynoid percent fat was signiﬁcantly
associated with decreased odds of elevated blood glucose
(OR= 0.87; 95% CI = 0.72–0.93), elevated BPs (OR = 0.82; 95%
CI = 0.71–0.99) and low HDL-cholesterol (OR= 0.59; 95% CI = 0.52–
0.91), while commingling of android percent fat and gynoid
percent fat was associated with increased odds of elevated
glucose (OR = 2.24; 95% CI = 2.01–2.93), elevated BP (OR= 1.82;
95% CI = 1.62–1.91), elevated LDL-cholesterol (OR = 1.77; 95%
CI = 1.50–1.89), elevated triglycerides (OR= 3.56; 95% CI = 2.61–
3.98) and low HDL-cholesterol (OR = 1.70; 95% CI = 1.49–2.93).
DISCUSSION
Despite the fact that locations of fat stores in the body are the
most critical correlates of cardiometabolic risk,25,26 generalized
adiposity (deﬁned with BMI) continues to be ubiquitous in the
epidemiologic literature. Unlike BMI-deﬁned generalized fat,
regional fat stores as seen in android and gynoid are more potent
because regional fat more easily undergoes lipolysis and readily
releases lipids into the blood. Android adiposity is characterized
by intra-abdominal (visceral) fat and is associated with increased
risk of cardiovascular disease, hypertension, hyperlipidemia,
insulin resistance and type 2 diabetes.27,28 Gynoid adiposity is
characterized by large amounts of subcutaneous fat and more
common in females than men, but is less associated with
cardiometabolic risk compared with android adiposity.29
Although different BMI-deﬁned adiposity phenotypes including
metabolically unhealthy and metabolically healthy obese subjects
are recognized, little is known about normal weight subjects who
have android and gynoid adiposities. Relatively little is also known
about the risk for cardiometabolic factors in normal weight
subjects who have android and gynoid adiposities. Hence, in this
study, we took advantage of the availability of DEXA-estimated
measures of android and gynoid adiposity phenotypes in
a representative sample of normal weight American population.
We used data from NHANES to determine the association of
DEXA-deﬁned elevated android and gynoid percent fat with
cardiometabolic risk factors, and also to determine whether
commingling of android and gynoid percent fat is associated with
greater cardiometabolic deregulations than either android or
gynoid adiposities in normal weight American adults. Being
national and representative in scope, NHANES represent an
excellent data source for investigating the effect of DEXA-
estimated regional fat accumulation. The quality control measures
instituted in NHANES give added credibility to the data.
The main ﬁndings
The result of this study indicates gender differences in prevalence
of android and gynoid in American adults of normal weight.
Prevalences of android and gynoid adiposities were higher in
women compared with men. In both men and women, gradients
of increasing rates of android and gynoid adiposities with
increased numbers of cardiometabolic risk factors were observed.
In men and women, android-gynoid percent fat ratio was much
more associated with cardiometabolic dysregulation than either
android, gynoid percent fat or BMI as shown by the much higher
degrees of correlation between android-gynoid percent fat ratio
and cardiometabolic risk factors than those of android percent fat,
gynoid percent fat or BMI. In men, increase in android percent fat
was correlated with increased values of triglycerides, LDL-
cholesterol and total cholesterol and decreased value of
HDL-cholesterol (Po0.05). In women, increase in android percent
fat was correlated with increased values of triglycerides, LDL-
cholesterol and decreased value of HDL-cholesterol (Po0.01). In
men, gynoid percent fat was correlated with increased values of
LDL-C and total cholesterol (Po0.01). In men, android-gynoid
percent fat ratio was correlated with increased value of SBP
and DBP, triglycerides and LDL-cholesterol, and negatively
correlated with HDL-cholesterol after controlling for age, smoking
and alcohol intake (Po0.05), while in women, android-gynoid
percent fat was positively correlated with triglycerides and
negatively correlated with HDL-cholesterol (Po0.05).
This study also showed gender differences in the response of
gynoid percent fat and joint occurrence of android elevated
percent fat and gynoid percent fat for cardiometabolic risk factors
that included elevated glucose, BP, LDL-cholesterol, triglycerides
and low HDL-cholesterol. In men, elevated android percent fat
(being in the highest tertile) was associated with 21% increased
odds of elevated BP, 141% elevated triglycerides and 23% low
HDL-cholesterol, controlling for age, BMI, smoking and alcohol
intake. Elevated gynoid (being in the highest tertile) was not
signiﬁcantly associated with increased odds of any of the studied
cardiometabolic risk factors. Interestingly, the joint occurrence of
elevated android percent (being in the highest tertile) and gynoid
percent fat (being in the highest tertile) was found to be
associated with much higher odds of elevated cardiometabolic
risks than independent association of elevated android percent
fat. The joint occurrence of android and gynoid percent fat was
associated with 60%, 19%, 48%, 2% and 25% much greater odds
for elevated glucose, BP, LDL-cholesterol, triglycerides and low
HDL-cholesterol, respectively, than the odds that is associated
with having only elevated android percent fat. In females,
elevated android percent fat was only signiﬁcantly associated
with increased odds of HDL-cholesterol. However, elevated gynoid
percent fat was associated with 13%, 18% and 41% decreased
odds of elevated glucose, elevated BP and elevated low HDL-
cholesterol, respectively. Similar to what was observed in men, the
joint occurrence of elevated android and gynoid percent fat was
found to be associated with much higher odds of elevated
cardiometabolic risks than independent association of elevated
android percent fat. The joint occurrence of android and gynoid
percent fat was associated with 61%, 55%, 48%, 75% and 65%
much greater odds for elevated glucose, BP, LDL-cholesterol,
triglycerides and low HDL-cholesterol, respectively, than the odds
that is associated with having only elevated gynoid percent fat.
Our ﬁndings of positive correlation between android percent fat
and android-gynoid fat ratio with triglycerides and negatively
correlation between android-gynoid fat ratio and HDL-cholesterol
are similar to the ﬁndings by Fu et al.,30 in 18–79-year-old Chinese
women. Like the result of this study, Fu et al.30 also found android
percent fat and android-gynoid fat ratio to be signiﬁcantly
associated with decreased odds of HDL-cholesterol. Our ﬁnding
is also in agreement with a study by De Larochellière et al.31 in
nonobese and apparently healthy young women and men. In the
study, accumulation of ectopic visceral adiposity in general, and of
visceral adipose tissue in particular, was found associated with
a worse cardiometabolic proﬁle whether individuals were over-
weight or normal weight. Our ﬁndings of positive association
between android percent fat and cardiometabolic dysregulation is
also in agreement with a study that was conducted in obese
children and adolescents which showed the positive association of
android fat distribution and insulin resistance.32 The present study
showed that android percent fat was much more positively
associated with some cardiometabolic risk factors in men.
This ﬁnding agrees with previous studies reporting that gluteo-
femoral fat, located in thigh or hip, is associated with decreased
cardiometabolic risks, including lower LDL-cholesterol, lower
triglycerides and higher HDL-cholesterol.33 Our ﬁndings of much
increased rate of android percent fat with 0, 1–3 and 4–5
cardiometabolic risk factors in both men and women compared
with gynoid percent fat is unclear, but may be due to the much
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higher correlation between android fat mass and visceral adipose
tissue compared with the correlation between gynoid fat mass
and visceral adipose tissue.24,25,34
Limitations
Some limitations must be taken into account in the interpretation
of results from this study. First, empirical sex-speciﬁc tertiles of
android percent fat and gynoid percent fat were used to deﬁne
elevated fat patterns, and subjects in the third tertile of android
and gynoid percent fat were regarded as having elevated android
and gynoid fat, respectively. The implication of using sex-speciﬁc
tertile values to deﬁne elevated fat patterns is unknown and
warrants investigation. Second, bias due to selection, misclassiﬁ-
cation, survey nonresponse and missing values for some variables
cannot be ruled out. However, previous studies based on data
from National Health and Nutrition Examination Surveys have
shown little bias due to survey nonresponse.35 Third, as a cross-
section study, directionality of the associations between depen-
dent variables and the independent variables cannot be clearly
established. Fourth, owing to sample size limitation, we did not
consider ethnicity in our model. Ethnic differences and impact of
race/ethnic differences in the association between regional fat
accumulation and cardiometabolic risks are well known.36 Hence,
one must be cognizant of limits of generalizability of the results
from this study to other groups and other countries, as well as the
limitations of statistical modeling techniques that were used.
CONCLUSION
Although android and gynoid adiposities measured by DEXA are
more expensive than current and much simpler and cheaper
measures (such as BMI), DEXA-deﬁned android and gynoid may
have important diagnostic utility in some high-risk populations
albeit of the adiposity status. Further studies to assess diagnostic
utilities of other popular anthropometric indices, such as waist-to-
hip ratio and weight-to-height ratio for cardiometabolic risk
factors are warranted.
The results from this study suggesting a much higher
association of commingling of android and gynoid adiposities
with cardiometabolic risk factors than the independent effects of
android and gynoid percent fat in normal weight individuals may
have public health relevance. Both android and gynoid fat
accumulations should be considered in developing public health
strategies for reducing cardiometabolic disease risk in normal
weight subjects. Normal weight subjects who present with joint
occurrence of android and gynoid adiposities should be advised
of the associated health risks such as cardiovascular disease and
metabolic syndrome.
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